Biden Admin Uses Wartime Powers To Boost Fed Role In Vaccine Distribution

NEW YORK, NEW YORK - DECEMBER 23: A member of FDNY EMS receives the coronavirus (COVID-19) vaccine on December 23, 2020 in New York City. Members of FDNY EMS were given doses of the Moderna coronavirus (COVID-19) vac... NEW YORK, NEW YORK - DECEMBER 23: A member of FDNY EMS receives the coronavirus (COVID-19) vaccine on December 23, 2020 in New York City. Members of FDNY EMS were given doses of the Moderna coronavirus (COVID-19) vaccine allotted for the department. Firefighters who are considered essential frontline workers but not essential health care workers will be able to receive the vaccine starting on December 29. The vaccine will not be mandatory for EMS workers or firefighters. (Photo by Michael M. Santiago/Getty Images) MORE LESS

The Biden administration has invoked a wartime law to boost vaccine production, taking a step towards alleviating supply shortages of the shot that could bring the COVID-19 pandemic to an end.

Biden COVID-19 adviser Andy Slavitt announced at a press briefing on Friday that the administration had invoked the Defense Production Act, a Korean War-era law that allows the federal government to compel the production of critical supplies.

Slavitt said that the order was partly responsible for Pfizer supplying more vaccines to the U.S. sooner.

“Last week, they announced an acceleration of their targets on when they’ll be able to deliver the vaccines,” he said. “I”m not going to say it’s the entire reason, but it’s a critical factor.”

It’s a marked departure from Trump administration policy of eschewing the tool in favor of letting states battle over limited supplies of PPE and vaccine, and comes as the Biden administration attempts to use the power of the federal government to coordinate the response to the virus.

Tim Manning, COVID-19 supply chain coordinator, said at the briefing that the administration was invoking the DPA to help Pfizer boost its production targets.

Those orders will put Pfizer first in line to receive filtration units and filling pumps from its suppliers. TPM has chronicled the difficulties in the vaccine supply chain and the potential use of the DPA to alleviate the problems.

The Biden administration has moved to strengthen the federal response in the vaccine rollout in other ways, as well.

The Pentagon announced on Friday that it had approved the deployment of 1,000 troops to support mass vaccination sites around the country.

These polices are new, and come after the Trump administration left the initial months of the vaccine rollout to the states.

“I would love to tell you that we were sitting on a stockpile of vaccines when we got here, but unfortunately that’s not the case,” Slavitt said.

Dear Reader,

When we asked recently what makes TPM different from other outlets, readers cited factors like honesty, curiosity, transparency, and our vibrant community. They also pointed to our ability to report on important stories and trends long before they are picked up by mainstream outlets; our ability to contextualize information within the arc of history; and our focus on the real-world consequences of the news.

Our unique approach to reporting and presenting the news, however, wouldn’t be possible without our readers’ support. That’s not just marketing speak, it’s true: our work would literally not be possible without readers deciding to become members. Not only does member support account for more than 80% of TPM’s revenue, our members have helped us build an engaged and informed community. Many of our best stories were born from reader tips and valuable member feedback.

We do what other news outlets can’t or won’t do because our members’ support gives us real independence.

If you enjoy reading TPM and value what we do, become a member today.

Latest News
Comments
Masthead Masthead
Founder & Editor-in-Chief:
Executive Editor:
Managing Editor:
Associate Editor:
Investigations Desk:
Reporters:
Newswriters:
Director of Audience:
Editor at Large:
General Counsel:
Publisher:
Head of Product:
Director of Technology:
Associate Publisher:
Front End Developer:
Senior Designer: